| Literature DB >> 31607110 |
Maria Efthymia Katsa1, Anastasios Ioannidis1, Athanasios Sachlas2, Ioannis Dimopoulos3, Stylianos Chatzipanagiotou4, Andrea Paola Rojas Gil1.
Abstract
PURPOSE: To estimate the roles of triglyceride/high-density lipoprotein cholesterol (TG/HDL) ratio and uric acid in predisposition for metabolic syndrome (MetS) and its components in healthy children.Entities:
Keywords: Child; Metabolic syndrome; Uric acid; Triglyceride/high-density lipoprotein cholesterol ratio
Year: 2019 PMID: 31607110 PMCID: PMC6790870 DOI: 10.6065/apem.2019.24.3.172
Source DB: PubMed Journal: Ann Pediatr Endocrinol Metab ISSN: 2287-1012
Mean values of the baseline characteristics in all studied categories (n=110)
| Characteristic | Children with predisposition for MetS (n=19) | Children without predisposition for MetS (n=91) | Children <9 years old (n=51) | Children ≥9 years old (n=59) | ||
|---|---|---|---|---|---|---|
| HDL | 66±13.9 | 66.98±11.9 | 0.753 | 68±11.1 | 65.6±13 | 0.275 |
| LDL | 117.5±15.6 | 88.7±16.1 | <0.001 | 91±17.9 | 93±20.6 | 0.753 |
| TG | 96.3±51.8 | 58.2±23.7 | 0.297 | 60.4±33 | 65.5±23.6 | 0.354 |
| Cholesterol | 196.47±19.9 | 157.3±21.9 | 0.001 | 165.2±23.5 | 163.8±28.4 | 0.633 |
| FBG | 86.2±4.1 | 85.95±6.25 | 0.860 | 85.1±5.96 | 86.8±5.9 | 0.129 |
| Uric acid | 3.29±1.05 | 3.37±0.93 | 0.749 | 2.99±0.82 | 3.67±0.9 | <0.001 |
| ALT/SGPT | 20.58±5.82 | 16.7±2.3 | 0.001 | 17.6±5.8 | 17.2±6.2 | 0.748 |
| AST/SGOT | 25.3±5.36 | 26.5±6.99 | 0.478 | 27.68±6 | 25.2±7.16 | 0.053 |
| ALP | 278.5±46 | 264,8±64.1 | 0.376 | 254.1±47.6 | 278.3±70 | 0.035 |
| GGT | 18.53±2.17 | 16.63±2.3 | 0.001 | 16.54±2.3 | 17.3±2.4 | 0.096 |
| CAD (cholesterol/HDL ratio) | 3.09±0.72 | 2.39±0.39 | <0.001 | mean:2.48±0.5 | mean:2.55±0.57 | 0.492 |
| TG/HDL ratio | 1.47±1.06 | 0.925±0.48 | 0.297 | 0.95±0.68 | 1.3±1.6 | 0.160 |
| BMI% | 81.5±23.8 | 58.7±32.29 | 0.004 | 63.9±33.8 | 61.8±30.9 | 0.735 |
| BMI | 0.81±1.18 | 0.48±1.2 | 0.308 | 0.75±1.04 | 0.38±1.3 | 0.095 |
| WC% | 95±0 | 83±21.6 | 0.023 | 86.89±21.2 | 85.3±19.3 | 0.888 |
| HC/WC | 1.17±0.17 | 1.13±0.086 | 0.079 | 1.12±0.114 | 1.12±0.156 | 0.836 |
| SBP% | 120±12.4 | 111.6±15.9 | 0.029 | 106.2±18.4 | 118.2±10.9 | <0.001 |
Values are presented as mean±standard deviation.
HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; FBG, fasting blood glucose; ALT/SGPT, alanine aminotransferase/serum glutamic-pyruvic transaminase; AST/SGOT, aspartate aminotransferase/serum glutamic-oxaloacetic transaminase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; CAD, coronary artery disease; BMI, body mass index; WC, waist circumference; HC, hip circumference; SBP, systolic blood pressure.
Correlation analysis study between TG/HDL ratio, biochemical markers and anthropometric characteristics in all studied categories
| Parameter | TG/HDL ratio | ||||
|---|---|---|---|---|---|
| Total population (n=110) | Children with Predisposition for MetS (n=19) | Children without Predisposition for MetS (n=91) | Children <9 years old (n=51) | Children ≥9 years old (n=59) | |
| HDL | |||||
| LDL | NS | NS | |||
| TG | |||||
| Cholesterol | NS | NS | NS | ||
| FBG | NS | NS | NS | NS | NS |
| Uric acid | NS | NS | NS | ||
| ALT/SGPT | NS | NS | NS | NS | |
| AST/SGOT | NS | NS | NS | NS | NS |
| ALP | NS | NS | NS | NS | NS |
| GGT | NS | NS | |||
| CAD (cholesterol/HDL ratio) | |||||
| BMI% | NS | NS | NS | NS | |
| WC% | NS | NS | NS | NS | NS |
| HC | NS | NS | NS | ||
| HC/WC | NS | NS | NS | NS | NS |
HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; FBG, fasting blood glucose; ALT/SGPT, alanine aminotransferase/serum glutamic-pyruvic transaminase; AST/SGOT, aspartate aminotransferase/serum glutamic-oxaloacetic transaminase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; CAD, coronary artery disease; BMI, body mass index; WC, waist circumference; HC, hip circumference; NS, nonsignificant.
Correlation analysis study between uric acid, biochemical markers and anthropometric characteristics in all studied categories
| Parameter | Uric acid | ||||
|---|---|---|---|---|---|
| Total population (n=110) | Children with Predisposition for MetS (n=19) | Children without Predisposition for MetS (n=91) | Children <9 years old (n=51) | Children ≥9 years old (n=59) | |
| HDL | |||||
| LDL | NS | NS | NS | NS | NS |
| TG | NS | NS | |||
| Cholesterol | NS | NS | NS | NS | NS |
| FBG | NS | NS | NS | NS | NS |
| TG/HDL ratio | NS | NS | NS | ||
| ALT/ SGPT | NS | NS | NS | NS | NS |
| AST/SGΟT | NS | NS | NS | NS | NS |
| ALP | NS | NS | NS | NS | |
| GGT | NS | NS | NS | NS | |
| CAD (cholesterol/HDL ratio) | NS | ||||
| BMI% | NS | ||||
| WC% | NS | NS | NS | ||
| HC | NS | NS | |||
| HC/WC | NS | NS | NS | NS | |
HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; FBG, fasting blood glucose; ALT/SGPT, alanine aminotransferase/serum glutamic-pyruvic transaminase; AST/SGOT, aspartate aminotransferase/serum glutamic-oxaloacetic transaminase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; CAD, coronary artery disease; BMI, body mass index; WC, waist circumference; HC, hip circumference; NS, nonsignificant.
Correlation analysis study between uric acid, biochemical markers and anthropometric characteristics in children categorized according to their BMI% and WC%.
| Parameter | Uric acid | |||
|---|---|---|---|---|
| Children with BMI%<85 (n=67) | Children with BMI%≥85 (n=43) | Children with WC%<95 (n=31) | Children with WC%≥95 (n=79) | |
| HDL | ||||
| LDL | NS | NS | NS | NS |
| TG | NS | NS | ||
| Cholesterol | NS | NS | NS | NS |
| FBG | NS | NS | NS | NS |
| TG/HDL ratio | NS | NS | NS | NS |
| ALT/SGPT | NS | NS | NS | NS |
| AST/SGΟT | NS | NS | NS | NS |
| ALP | NS | NS | NS | |
| GGT | NS | NS | NS | |
| CAD (cholesterol/HDL ratio) | NS | NS | ||
| BMI% | NS | NS | NS | NS |
| WC% | NS | NS | NS | |
| HC | NS | NS | NS | NS |
| HC/WC | NS | NS | NS | NS |
BMI, body mass index; WC, waist circumference; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; FBG, fasting blood glucose; ALT/SGPT, alanine aminotransferase/serum glutamic-pyruvic transaminase; AST/SGOT, aspartate aminotransferase/serum glutamic-oxaloacetic transaminase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; CAD, coronary artery disease; HC, hip circumference; NS, nonsignificant.